MIBG-scintigraphy: best clinics abroad

MIBG scintigraphy is a nuclear medicine examination that maps tissues taking up metaiodobenzylguanidine labelled with a radioactive tracer. In cancer care, it has specific uses, including assessment of neuroblastoma, pheochromocytoma and paraganglioma. Images may help identify disease sites, assess the extent of disease or compare findings after treatment. The referring team chooses the examination according to the diagnosis, earlier imaging and the clinical question. It does not detect every type of tumour, and a negative scan cannot provide a general guarantee that cancer is absent.

Assessment abroad may be useful when access to specialist nuclear medicine, combined review of imaging and treatment options, or another opinion is needed. Before travelling, confirm tracer availability, preparation and the full appointment schedule. Send previous images, reports, laboratory results and a medication list. Request a written quotation covering the planned imaging and clinical review. A diagnostic MIBG scan and treatment with radioactive MIBG are separate procedures with different requirements.

What the scan can show

Some tumours of neuroendocrine origin take up MIBG. The examination may help locate disease, assess its distribution or compare findings over time. Diagnostic imaging commonly uses iodine-123-labelled MIBG. Uptake can inform discussion about MIBG therapy, but does not establish treatment eligibility by itself. The choice of imaging depends on the tumour and the decisions of the oncology team.

Arrange preparation in advance

Tell the department about possible pregnancy, breastfeeding, allergies and every medicine, including products bought without a prescription. Some medicines interfere with tracer uptake. Any pause must be agreed with the treating clinician; do not change medication yourself. Thyroid protection is prescribed according to the department's protocol. Confirm how to obtain it, when to start and when to finish. Ask for instructions about food, fluids and companions.

Appointments and image acquisition

The tracer is slowly injected into a vein; staff may monitor blood pressure. There is then a waiting period while it distributes through the body. A gamma camera records images while you lie still. SPECT/CT may be added to locate areas of uptake more precisely. Many protocols require visits on two days, with initial images several hours after injection and further images the following day. An imaging session may take around 30–90 minutes; extra views can extend it. Confirm the complete timetable and any need for a child's sedation before booking travel.

Aftercare and interpretation

The test involves ionising radiation, so the team weighs its expected benefit against individual risk. Reactions to the tracer can occur. Seek immediate help for breathing difficulty or a severe reaction. Obtain personal instructions about fluids, breastfeeding and close contact with other people. Ask about a travel letter, because residual radioactivity may trigger airport monitors. A specialist interprets the images alongside CT, MRI, laboratory findings and other evidence. Confirm when the report and image files will reach the referring clinician.

Comparing quotations

Charges may cover the tracer, separate imaging sessions, SPECT/CT, sedation, reporting and consultation. Check the policy for additional views, rescheduling and translated documents. Compare the same scope of care, including a plan for discussing the result.

Frequently asked questions

Does the scan treat a tumour?

No. Diagnostic imaging records tracer distribution. MIBG therapy is a separate treatment programme requiring its own assessment.

Does a negative scan exclude disease?

No. Some tumours do not take up MIBG. Other investigations and the clinical situation remain relevant.

Can I fly home after the injection?

Confirm the schedule first. Further images are often needed the next day, together with individual instructions after tracer administration.